Pursuant to Clause 9 of the COVID-19 Public Health Response (Point-of-care Tests) Order 2021 (“Order”), I, Robyn Shearer, Acting Director-General of Health, exempt the following point-of-care rapid antigen test from all prohibitions under clause 7 of the Order.
Product name(s): SARS-CoV-2 Antigen Kit (Colloidal Gold)
Manufacturer (country): Goldsite Diagnostics, Inc. (China)
Sample type(s): Nasal swab
Product configuration: Self-test of any package size
Dated at Wellington this 26th day of May 2022.
ROBYN SHEARER, Acting Director-General of Health, Ministry of Health.